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Cell encapsulation has been widely studied as an alternative therapy for 
almost every human diseases and disorders. This technique enables the 
inclusion of various types of living cells inside spherical systems which, among 
other capabilities, mimic the environment provided by the extracellular matrix. 
This new therapeutic approach has already proved to be successful either in 
vitro or in vivo studies, thus becoming one of the most promising tools in tissue 
engineering and regenerative medicine.  
The main goal of this thesis was to explore some of the potential of cell 
encapsulation using simple and versatile techniques that can be performed in 
physiological and friendly conditions to the cells.  
In a first approach, cells were encapsulated in liquid-core capsules using 
a three step methodology: (i) the precipitation of a polymer solution of alginate 
into a bath of calcium chloride (ionotropic gelation), (ii) deposition of 
polyelectrolyte multilayers onto the surface of the beads, in a process called 
layer-by-layer. (iii) use of EDTA to liquefy the alginate core. Two different 
natural-based polymers were used, alginate, the most studied copolymer for cell 
encapsulation and chitosan, a polymer widely explored in a variety of 
biomedical applications. Both polymers were proved to be biocompatible, 
biodegradable and can be manipulated under physiological conditions.  
All the capsules produced exhibited spherical shape, smooth surface and 
liquid-core. The results shown that encapsulated cells were viable and 
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proliferating few days after the alginate-chitosan multilayer buildup, which 
suggests that the develop capsules posses a semipermeable membrane which 
allows the correct diffusion of nutrients and metabolites.  
A preliminary study was started to test the feasibility of culturing 
anchorage-dependent cells in PLLA solid microparticles previously treated with 
human serum fibronectin followed by the encapsulation of the whole set in 
alginate-chitosan liquid-core capsules. The results are still very incipient but 
















Preparation and characterization of polysaccharide multilayered capsules 




O encapsulamento de células tem sido amplamente estudado como 
alternativa terapêutica para quase todas as doenças e distúrbios que afectam a 
humanidade. Esta técnica permite a inclusão de vários tipos de células vivas 
dentro de sistemas esféricos que, entre outras capacidades, mimetizam o 
ambiente criado pela matriz extracelular. Esta nova abordagem terapêutica já 
deu provas do seu sucesso em estudos quer in vitro ou in vivo, tornando-se um 
dos instrumentos mais promissores na engenharia de tecidos e medicina 
regenerativa. 
Esta tese teve como principal objectivo a exploração de alguns dos 
potenciais de encapsulamento de células recorrendo a técnicas simples e 
versáteis passíveis de serem realizadas em condições fisiológicas e favoráveis 
para as células. 
Numa primeira abordagem, foram encapsuladas células em cápsulas de 
núcleo líquido usando uma metodologia trifásica: (i) precipitação de uma 
solução de polimérica de alginato num banho de cloreto de cálcio (gelificação 
ionotrópica), (ii) deposição de multicamadas polieletrólitas na superfície das 
partículas, num processo denominado layer-by-layer (iii) liquefacção do núcleo 
de alginato com recurso a uma solução de EDTA. Dois polímeros naturais 
diferentes foram utilizados, o alginato, o copolímero mais estudado para 
encapsulamento de células e o quitosano, um polímero amplamente explorado 
nas mais variadas aplicações biomédicas. Ambos os polímeros já mostraram 
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ser biocompativeis, biodegradaveis podendo ser manipulados em condições 
fisiológicas.  
Todas as cápsulas produzidas exibem uma forma esférica, lisa e núcleo 
liquefeito. Os resultados mostraram que as células encapsuladas eram viáveis 
e proliferavam poucos dias após a construção das multicamadas de alginato-
quitosano, o que sugere que as cápsulas desenvolvidas possuem uma 
membrana semipermeável que permite a difusão adequada de nutrientes e 
metabólitos. 
Um estudo preliminar foi iniciado com o intuito de testar a viabilidade do 
cultivo de células dependentes de ancoragem em micropartículas sólidas de 
PLLA previamente tratados com fibronectina humana seguido do 
encapsulamento de todo o conjunto em cápsulas líquidas de alginato-
quitosana. Os resultados são ainda muito incipientes, mas bastante 
promissores. 
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AC – alginate/chitosan capsules 
ADC – anchorage dependent cells 
ALG/CHI multilayers – 8 polyelectrolyte 
alginate/chitosan multilayer 
APA – alginate/poly(L-lysine) capsules 
B 
Ba2+ - barium cation 
BSA – bovine serum albumin  
C 
Ca2+ - calcium cation 
CHO –  
CO2 – carbon dioxide  
D 
DMEM – Dulbecco’s Modified Eagle 
Medium  
DNA - Deoxyribonucleic acid 
E 
ECM – extracellular matrix 
EDTA - Ethylenediamine tetraacetic 
acid 
F 
FBS – fetal bovine serum  
H 
HPC – high polyelectrolyte 
concentrated solution 
I 
IG – ionotropic gelation 
L 
LbL – layer by layer 
LPC – low polyelectrolyte concentrated 
solution 
L929 – mouse fibroblastic lung cell line 
M 
Mg2+ - magnesium cation 
Min - minutes 
MTS -  
MWCO – molecular weight cut off 
N 
NaCl – sodium chloride 
NaOH – sodium hydroxide  
O 
O.D – optical density 
P 
PBS – phosphate saline buffer 
PEC – polyelectrolyte coating 
PLL – poly(L-lysine) 
PLLA – poly(L-lactic) acid 
Q 
QCM – D – quartz crystal microbalance 
with dissipation 
R 
RGD – Arginine – Glycine – Aspartic 
acid 
S 
SaOs-2 – human sarcoma osteoblastic 
cell line 
SEM – Scanning Electron Microscopy 
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∆f (n) – normalized frequency 
∆D – dissipation 
µ - CT – micro computerized tomography 
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Chapter I: Bioencapsulation in liquid-core capsules- General 
Introduction 
1.1 – Motivation  
During the last decades the biomedical field has been experiencing a 
new approach regarding the development of systems to encapsulate living cells 
or tissues. Each of these systems through their possible application follows a 
specific pattern that results from a combination of materials with particular 
physical, chemical and biological behaviors.  
For these systems be considered ideal for biomedical application is 
necessary to provide properties such as biocompatibility, adequate mass 
transport properties and mechanical characteristics, and, in some cases, 
biodegradability. The size, shape and chemical composition of such devices 
should also be adequate to be possible their implantation within the host 
organism without triggering any excessive immune response.  
Numerous encapsulation techniques have been developed over the 
years. These techniques are generally classified as microencapsulation 
(involving small spherical vehicles and conformably coated tissues) and 
macroencapsulation (involving larger flat-sheet and hollow-fiber membranes)[1] 
A wide range of polymeric materials, both natural and synthetic, has been 
proposed for these encapsulation systems, being the alginic acid, PLL and 
chitosan the most representative polymers used in this approach. 
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Cell encapsulation makes possible a number of biological advantages 
formerly impartibly, in particular enables the transplantation of xenogenic animal 
and human cells, allows the transplantation of genetically modified cells without 
the commitment of the entire genome of the host and is a process in which 
factors potentially toxic are reduced once the capsule acts as an insulation 
system. 
Regarding their structural and mechanical properties, encapsulated 
systems have been first proposed for immunoprotection of grafted cells in living 
organs.[2] Nowadays, much more applications have been proposed, ranging 
from therapeutic treatments, cell delivery molecules until cellular biosensors.[3] 
This review will focus on different methodologies to obtain liquid-core 
capsules for cell encapsulation. First we will make a general overview about the 
bioencapsulation and the properties required to create a suitable cell 
encapsulation system. Second we will describe the techniques that allow 
obtaining liquid-core capsules under mild conditions. Finally, we will introduce a 
new methodology to encapsulate living cells in liquid-core capsules using the 
LBL technology.  
 
1.2 – Bioencapsulation 
Bioencapsulation or encapsulation of living cells and biological active 
compounds within a semipermeable membrane is a promissing technique which 
provides added possibilities for complex cell-based therapies, once it allows 
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allogenic and xenogenic cell transplantations without the further need of 
immunesuppressive therapy.[4-9] The semipermeable membrane have two main 
functionalities: on one hand it protects the inner cells from both mechanical 
stress and the host immune system, by preventing the direct contac with 
immune cells (immunoglobulins and other immunological constituints)[10-12], on 
the other hand it allows the free and bidirectional exchange of nutrients, oxygen, 










Since it was first introduced in 1964 by Chang[15], encapsulation of living 
cells in spherical vehicles have become the most investigated technique for 
producing biological agents such as monoclonal antibodies by immobilized 
hybridoma cells[16], enzymes and peptides entrapping genetically modified 
Figure1. 1: schematic representation of a typical bioencapsulation system. (A) semipermeable 
membrane allowing the free bidimensional diffusion of nutrients and metabolites. (B): 
microcapsules used for cell transplantation in a tissue engineering approach. Adapted from [10] 
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cells.[8] Researches in pharmacology recently set up these devices as promising 
systems for continuous cells delivery of therapeutic products in vivo.[6, 13, 17] 
Over the past decade, a wide variety of spherical cell encapsulation 
vehicles have been developed. Considering their structural properties, they can 
be classified in three different categories. The first one comprises currently 
designated as “microparticules” - vehicles with a solid-core, where the cells 
enclosed are surrounded by a solid gel matrix. Usually in solid gel matrix only 
few and small porous are formed inside the solid network inhibiting the cell 
proliferation by exerting a microscopic stress around the enclosed cells.[18, 19] 
However, the mechanical stability is high in solid microparticles which makes 
them suitable for long term in vivo studies or in cases where it is necessary to 
control the quantity of therapeutic protein provided to the body from the 
transplanted cells.[17, 20]  
The second category includes vehicles with a liquid core matrix called 
“microcapsules”. Two main types of capsules can be produced from this 
concept point of view. (1) Hollow-core capsules, where the cells are surrounded 
by liquid that permeates through the capsule membrane from the surrounding 
medium or body fluid[17, 21] and (2) liquid-core capsules, where the original solid 
core is solubilized giving rise to a an aqueous liquid matrix, which surrounds the 
entrapped cells[22-25]. In both microcapsules cell entrapped are not subjected to 
above mentioned microscopic stress so, the cells faces a more preferable 
environment for cellular proliferation and preferred protein secretion.[26, 27] 
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The third category includes systems, generally designated as 
“macrocapsules”, which are normally much larger than microcapsules and 
possess a planar or cylindrical geometry. Macrocapsules generally possess 
diameters >1mm and are very useful as a basic research tool for primary 
understanding of fundamental immunological an biological behavior of the 








From a biological and structural point of view, microcapsules have (1) 
higher surface-to-volume ratio providing considerable improve in mass transport 
and (2) lower volume implant comparatively with macrocapsules. On the other 
hand macrocapsules have high loading capacity and high rate of recovery.  
 Along with the type of vehicle selected for cell encapsulation many other 
parameters has to be considered. The immunological isolation conditions as 
well as the materials used to produce the semipermebale membrane are closely 
related with the further application of the system and will be crucial for its 
success after implantation. Over the last 20 years several natural and synthetic 
Figure1. 2: schematic representation of the different types of microcapsules 
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polymers have been studied as potential devices for bioencapsulation[29-33] 
being the microcapsules for pancreatic islets encapsulation the most 
researched device applied.[34-36] Nowadays a new range of implantable systems 
based on biencapsulation has been applied in a wide range of therapies 
approaches such as hypoplastic anemia[37], immunoisolation in cancer 
therapies[38-40], treatment of hyperparathyroidism[41] and in central nervous 
system disorders.[42] The great majority of these therapies involve the 
production and release of de novo proteins like growth factors [21], DNA [43, 44], 
enzymes[45, 46], and antibodies.[16]  
Molecular weight cut of (MWCO), i.e., the upper limit of capsule 
permeability, is another important property with regard to bioencapsulation 
since it specifies the inflow and outflow of the products across the membrane.[1, 
20] The encapsulation fabrication process, which will be discussed later in this 
review, is another factor of great importance in bioencapsulation. 
 
1.3. – Liquid-core capsules for cell encapsulation  
The encapsulation of living and functional cells or bioactive compounds 
usually requires a matrix capable of providing a water-rich environment. Most 
commonly, this matrix is a hydrogel frequently produced in a spherical 
geometry.[29]  
Hydrogels are networks of water-soluble polymers that can be produced 
by different crosslinking methods compatible with cell viability which usually 
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involves non-covalent crosslinking.[47, 48] Generally hydrogels present reversible 
structures which can be disrupted in response to changes in temperature, ion 
concentration and pH.[49] These polymers provide some advantages properties 
for living cells encapsulation such as (1) softness and malleable environment 
that reduce the friction between surfaces of the capsules and the surroundings 
(2) hydrophilic behavior, which theoretically reduces the surface tension 
between the capsule and the surrounding liquid medium, thus reducing the 
affinity of proteins and host cell adhesion on the surface of the material and (3) 
enables a selective permeability to the extent that it only allows the diffusion of 
low molecular weight substances at the expense of others high molecular 
weight.[1, 48, 50, 51] Moreover, due to the ease with which they can be manipulated 
hydrogels usually are tailored to be biocompatible and biodegradable for 
biological applications.[52] 
Microparticles with solid-core were the first and most common way of 
producing bioencapsulation systems based on hydrogels. There are a plenty of 
studies where solid-core microparticles were used to encapsulate bone marrow 
stem cells[53], cartilage precursors[54], hepatocytes[55], myoblasts[8] among 
others. Due to their small implant site which requires nothing more than a small 
and non-invasive surgical procedure and their feasibility to conveniently adjust 
to the implantation site microcapsules became a very attractive alternative as 
cell carriers for tissue engineering. However, in a solid spherical structure, the 
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cells in the inner zone are subjected to a lower intake of oxygen and nutrients 
thus becoming necrotic.[12, 18] 
In recent years liquid-core capsules has been receiving great attention as 
an alternative for cell encapsulation instead of solid-core microcapsules. The, 
higher diffusivities of oxygen, nutrients, and metabolites in a liquid than in a gel 
seem to be a strong reason for the higher cellular growth and survival in liquid-
core microcapsules.[24, 49] Sun et al. have demonstrate that cell enclosed in 
liquid-core capsules are more resistant to hyperosmotic stress, oxidative stress 
and heat shock stress than cells encapsulated in solid-core capsules.[24] In a 
different study, Breguet and its coworkers demonstrate that CHO cells growth 
more when encapsulated in a batch of liquid-core capsules.[27]  
Up to now there are very few techniques that allow the encapsulation of 
living cell in liquefied capsules. Interfacial phase polymerization was the first 
technique proposed to encapsulate cells in liquid-core. In this approach liquid-
core capsule are formed using monomers dissolved in the respective immiscible 
phases. Briefly, a polymeric aqueous solution containing cells can be dispersed 
into an oil phase by stirring. The capsule is immediately formed by addition of 
another organic solvent soluble into the continuous organic phase (oil).[46] 
However, this technique requires always the use of organic solvents that can 
compromise cell viability and it is only used for encapsulation of microbial cells 
or biocatalysts.[22] To overcome these adversities, new alternatives for cell 
encapsulation have been proposed. The next topic will be presented two 
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techniques that currently allow encapsulating living cells in liquid-core capsules 
under physiological conditions without the further use of harsh treatments.  
 
1.3.1. Techniques for cell encapsulation under mild conditions  
In the design of novel capsules the perfect adaptation of the construct 
device to the cell properties are the basis for cell survival and encapsulation 
success. Methodologies that can ensure a microenvironment that could mimic 
the extracellular matrix or the culture conditions, in which the cells are used to 
live, must be preferred. Ionotropic gellation[56] and capsule wall formation by 
polyelectrolyte[49] deposition are two simple techniques widely used in cell 
encapsulation studies in liquid-core capsules.  
Ionotropic gelation (IG) is a phenomenon that occurs when a 
polyelectrolyte solution (anionic or cationic) is brought into contact with an 
multivalent counterion in a receiving bath[57] - see Fig.2A. The gelation is 
instantaneous and the resulting structure depends on both molecular and 
physico-chemical properties of polyelectrolyte and also on the type of 
counterion used in the process.[58] Usually the gelation takes place at the 
interface between the both solutions therefore theoretically the capsule interior 
remains liquid or semi-liquid[49]. However, the most studied polymer for cell 
encapsulation is the alginate which in a presence of a divalent counterion bath 
such as calcium or barium forms rigid beads.[59-61] In order to obtain liquid-core 
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gels from these solid beads a treatment with divalent chelator like EDTA or 
sodium citrate is always required - see Fig.2C.  
Ionotropic gelation is a gentle gelation and cell compatible process which 
can be performed under room temperature at mild conditions so the living cells 
can be suspended in the polymer solution even before the encapsulation 
procedure takes place.  
Ionotropic gels generally suffer degradation by slow exchange of divalent 
and monovalent cations, leading to the dissociations of ionic bridges[59].so, most 
of the time, these gelified structure must be stabilized using adjuvant polymers, 
such as poly(L-lysine)[43, 62], poly(ethyleneglycol)[11]our chitosan[6, 63] among 
others. Orive et al have produced alginate and poly(methylene-co-guanidine) 
(PMCG) microcapsules for cell encapsulation. According to their study, PMCG 
is a polycationic methylol amid which improves the uniformity of size beads, wall 
thickness and mechanical stability of the cell encapsulation devices.[20] 
Capsule wall formation by PE deposition or PE coatings (PEC) is a 
simple coating methodology based on the alternatively dipping of oppositely 
charged polymers (polycationic or polianionic) in order to form a polyelectrolyte 
film (see Fig.2B).[64] The success for such technique relies on the choice of the 
oppositely charged polyelectrolytes and in the deposition conditions[65]. Several 
polyelectrolytes can be used to form layered structures onto the surface of solid 
or liquid materials by means of simple electrostatic adsorption. Thickness of this 
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PECs can range from few nanometers up to several micrometers depending on 
the number of deposited layers.[44] 
PEC is the major contributor for the success of bioencapsulation. These 
coatings can be performed around encapsulated cells for liquid-core capsules 
fabrication[16, 19, 20] or directly around the cells[5, 66-68] for “single” cell coating. The 
formation of a polyelectrolyte membrane will provide and additional mechanical 










The versatility and universal character of PEC does not impose any 
limitation on the type of polyelectrolyte applied. Until now, several charged 
macromolecules such as synthetic and natural polymers, proteins[7], 
Figure1.3: under mild conditions. A: ionotropic gelation of a polymeric cell suspension in a 
multivalent ionic bath B: Polyelectrolyte coating for capsule wall formation; C: liquid-core 
capsule obtained after core treatment with a chelator agent. 
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immunoglobulins[69] and nucleic acids[43] have been used as films building 
blocks. Diaspro et al have encapsulated single living yeast cell by alternate 
adsorption of labeled polyelectrolytes.[70] Germain et al coated MELN cells using 
oppositely charged polyelectrolytes, proving that it is possible to directly coat 
living mammalian cells with more than 5 bilayers in a cell friendly environment.[3] 
Table 1 summarizes a few studies where IG and PEC were combined to 
produce liquid-core capsules under mild conditions.  
Table1.1: Cell encapsulation approaches using ionotropic gelation and polyelectrolyte coating.  
 
1.4. – Layer-by-layer electrostactic assembly as a vehicle to obtain liquid core 
capsules 
As mentioned above, the coating of microparticles is a powerful tool in 
obtaining encapsulated systems with better physical and chemical properties. 
The deposition of polyelectrolyte multilayer films [64] represents an alternative 
solution for biomaterial coating.[73] Matching cells to multilayers assemblys is a 
relatively recent activity that has revealed some of the most promising 
properties of multilayered membranes, where hydrophobicity[74, 75] 
Technique Core Polymer Core liquefaction 
method 
Cell encapsulated References 
Ionotropic 
gelation 
Alginate/Ca2+ Citrate CHO 
C2C12 myoblast 











CRFK cells [72] 
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composition[76, 77], and stiffness[78] may be tuned by the components, conditions, 
and sequence of layering. The adhesion, proliferation and differentiation of cells 
are directed in a large extent by the multilayer constructs.  
The layer-by-layer (LbL) assembly was first introduced in early 1990’s by 
Decker and co-workers[77, 79] for the preparation of nanoscaled controlled films 
for biomedical applications.[68, 80] The LbL methodology may be employed in the 
production of capsules through the sequential deposition of polymers 
assembled by complementary interactions (e.g., electrostatic, hydrogen 
bonding, and covalent linkages) on template particles, followed by removal of 
the templates. This facile yet versatile technique can incorporate a large variety 
of polymers.[79], templates[69] and also allows the buildup of multilayers from 









Figure1.4: layer-by-layer under spherical templates. Adapted from [79] 
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Mechanical stable capsules can be obtained by LbL assembly.[45, 80, 82] 
The multilayers produced will act as a shielding structure with the ability to 
protect bioactive molecules in a define volume while creates a special defined 
microenvironment for the loadings.[83] In the case of liquid-core capsules LbL 
allows obtaining structures with improved mechanical strength whose 
toughness of the membranes will be greater the higher the number of 
multilayers deposited. To date only few studies about the encapsulation of cells 
in liquid-core capsules constructed using the LBL technique has been reported 
(see table 1). So far, those capsules were made with no more than 4 layers.[27]  
 In principle such methodology could be use to produce capsules 
containing cells coated with nanostructured multilayers proving that the cells 
can be incorporated inside the initial template particles and that they can be 
eliminated under mild conditions.[67,68]. This possibility could allow to produce 
coatings with tunable thickness (and thus controllable permeability) and surface 
characteristics that could be very attractive for cell isolation and 
transplantation.[16,69] 
Our group recently investigated the combination of two different 
techniques to achieve a suitable cell encapsulation system for further use in 
tissue engineering and regenerative medicine. Merging encapsulation 
techniques with LbL self assembly, liquid core capsules whose walls are 
composed by nanostructured multilayers were successfully produced. Cells 
were entrapped inside the conceived capsules and cultured for a certain period 
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of time to evaluate its biological ability. With this formulation it is expected to 
obtain a permeable and tight mechanical structured system which could be able 
to ensure the cell viability and provide effective cell immunoisolation. Moreover, 
it is also expect that with this versatile technique some membrane features like 
mechanical properties and biological behavior could be tuned by varying the 
composition and number of layers, or by introduction of bioactive molecules. 
 
1.5. Conclusion 
Biencapsulation in liquid-core capsules is gaining enormous interest in 
the field of tissue engineering and regenerative medicine. The combination of 
basic encapsulation methodologies like ionotropic gelation with layer-by-layer 
technique may lead to obtain capsules with versatile and tunable mechanical 
and biological properties. Although to ensure the cell viability inside these 
devices, material properties must be controlled to facilitate the desired 
metabolic functionality. Many efforts have been made along the past few years 
to develop tunable materials that will impart the correct biological and 
mechanical signals to the cells. Up to now, liquid-core capsules prove to be a 
suitable system in which the cells can grow and proliferate correctly. However a 
lot of work remains to be done in this field, which makes it an attractive research 
area with increasing interest for the future. 
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Chapter II – Materials and Methods  
Polysaccharides are a very important group in the field of water soluble 
polymers where they play a major role as “thickening, gelling and emulsifying 
hydrating and suspending” materials. Most of these polymers give rise to 
physical gels at mild conditions under specifically thermodynamic 
circumstances.[1] Natural-based polysaccharides have been widely recognized 
for biomedical applications due to their similarity to biological macromolecules 
namely the extracellular matrix (ECM) ones. This property may represent an 
immunological advantage for these polymers because when implanted in 
human host, they may avoid the stimulation of immune cells and consequent 
citotoxic reaction. Moreover, they can be frequently degraded in vivo.[2, 3] 
In this chapter, the key features of the materials used in the development 
of this work as well as all the procedure for their manipulation and 
characterization will be described in detail. 
 
2.1. Polymers used 
2.1.1.  Alginate  
Alginate has been widely employed as polymeric matrix in cell 
immobilization procedures.[4] It is considered a suitable polymer for 
microcapsules fabrication since it is not harmful for host tissue and because of 
its high ability to form rigid gels under mild and physiological conditions in the 
presence of few amounts of divalent cations.[5-7] In tissue engineering 
Preparation and characterization of polysaccharide multilayered capsules 





applications alginate has shown to provide mechanical integrity while 







Alginate is a naturally derived polysaccharide very abundant in structural 
components of marine brown algae and capsular components of soil bacteria.[3] 
The term alginate is referred to a range of polysaccharide block copolymers 
composed of both (1) sequential regions of β-D-mannuronic acid monomers (M-
blocks) and α-L-guluronic acid (G-blocks) (2) interspaced M and G blocks – see 
Fig.2.1.[1, 9, 10] This polymer can be reversible gelled in aqueous solutions when 
mixed with divalent cations (Ca2+, Mg2+, Ba2+) [11, 12]. At mild conditions, divalent 
cations interacts with the carboxyl groups located on the polymer backbone, 
namely G-blocks, creating a three dimensional network by ionic inter-chain 
bridges. The ratio of M/G contents as well as the individual distribution of both 
M and G units along the chain will establish the physical properties of alginate in 
Figure2.1: Chemical structure of alginate. (A) α-L-guluronic acid (G-blocks) (B) β-D-
mannuronic acid monomers (M-blocks) (C) interspaced M and G blocks. Adapted from [1] 
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aqueous solutions.[1] Also the stiffness of the alginate chains and further calcium 
complex formation depends on the mannuronic and guluronic ratio and 
distribution along the polymer chain.[13] 
Alginate gel matrix surface can be modified by income of 
macromolecules which are capable to establish ionic interactions with its 
carboxilate ions.[10] This surface modification may provide additional mechanical 
integrity to the matrix.[14] Alginate is been largely used as a matrix to prepare 
microcapsules to be used as cell immobilization matrix[15-18], involving different 
cell sources such as stem cells[19-22], pancreatic islets[23-25] and a wide range of 
human and microbial cells.[26-31] Moreover alginate microcapsules have been 
used in means of cell delivery vehicles[32-35], cells transplantation context[36-40] 
and even in food and flavors encapsulation.[41] 
Alginate in its purest form could be an extremely biocompatible barrier.[42] 
The pure form of this polymer has shown to have a high content of impurities 
and mitogenic fractions, which may lead to overgrowth fibrotic tissue when 
implanted in animal models.[12] Purification substantially reduces the host 
response to the material. On the other hand, an additional coating with 
polycationic in the outer shell of alginate microcapsules could lead to a better 
biocompatibility of the implanted material.[14] Besides this drawback, alginate is 
one of the most studied and applied polymer in the field bioencapsulation, due 
to its promising properties as a natural-based polymer.[43] 
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For this work, low viscosity sodium alginate seaweed from brown algae 
was purchased from Sigma-Aldrich, Portugal. Alginate solutions prepared with 
different concentrations. A 1% (w/v) alginate solution was obtained by polymer 
dissolution in 0.15M sodium chloride (NaCl Sigma-Aldrich, Portugal) aqueous 
solution. The alginate solutions used for the layer-by-layer polyelectrolyte 
assembly were prepared with both 0.05% (w/v) and 0.1% (w/v) in 0,15M NaCl 
aqueous solutions. The pH was adjusted up to 7 with 1M of sodium hydroxide 
(NaOH) or 1M citric acid (C6H8O7). All the polymer solutions were prepared in 
distilled water, autoclaved (121ºC, 30min) and vacuum-filtered in a 22µm pore-
size filter (Schleicher & Schuell Microscience, Germany) to sterilize. The 
solutions were then stored at 4ºC for further use.  
 






Chitosan is a natural and linear copolymer of D-glucosamine and N-
acetyl-D-glucosamine linked in β (1-4) (Fig.2.2). Usually it derives from chitin, 
the main organic polymer found in crustaceous shells, cuticles of insects and 
cell walls of some fungi.[1, 45, 46] Considering its wide and variable application, 
Figure2. 2: chemical structure of chitosan. Adapted from [44]  
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chitosan has been formulated as powders, gels, films and spherical micro and 
nanoparticules, among others.[46] Nowadays chitosan have been investigated as 
surface modifier for a wide range of biomedical applications.[47] Song et al used 
this polymer to enhance the biocompatibility of self-assembled membranes[48], 
Antipov and co-workers used chitosan as core-shell structures[33, 49] and many 
other groups has been exploring the chitosan as a local drug delivery[50, 51] and 
bioactive nanocoatings for endovascular devices.[52] 
Solubility is a crucial characteristic for chitosan. As a naturally positively 
charged polymer with a high charge density in acidic medium chitosan usually 
forms insoluble complexes with water-soluble polyanionic species at neutral 
conditions.[53] Qin et al (2006) reported that at physiological pH water-insoluble 
chitosan molecules can precipitate and stack on the microbial cell surface, 
thereby forming an impermeable layer around the cell which can be fatal for 
living cells. The formation of such layer can block the transport of essential 
moieties and may also destabilize the cell wall causing its severe leakage 
leading ultimately to cell death.[45] So, improving the chitosan solubility will 
largely facilitate its application in medicine and food industry.[54] Moreover, 
Chung et al (2003) confirmed that chitosan possess a broad spectrum of 
antimicrobial activities but, regarding its low solubility at neutral pH, its 
application can be limited.[55] On the other hand, soluble chitosan showed 
higher antimicrobial activity against E. coli, B.subtilis and S. aureus than crude 
chitosan[56] have found out that water soluble chitosan promote growth of 
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C.albicans at physiological pH, even though the optimal ph for C.albicans 
growth is 5.5, thus proving the low cell – toxicity. Moreover, it has been reported 
in several studies that water soluble chitosan had better physiological 
performance in antitumor activity and immune-enhancing in vivo effects. [57, 58] 
Considering aforementioned, water soluble chitosan seems to be a suitable 
formulation to be applied in systems for cells.  
Currently, many companies are now suggesting different procedures to 
enhance the chitosan solubility[1], among them pure chitosan for medical 
application are the most interesting ones, since they are able to be prepared 
under physiological pH at room temperature. Protosan UP Chitosan from 
NovaMatrix (FMC Norway) is an example of a water soluble chitosan which can 
be manipulated under mild conditions.[59] 
For this work, Protosan Ultrapure Chitosan (Novamatrix, FMC Norway) 
was used according to previous results obtained by Martins et al (2009). 
Ultrapure chitosan PROTOSAN UP CL213, viscosity 107mPa.s, 
molecular weight Mw=2,7x105g/mol and degree of deacetylation DDA=83% was 
used to prepare the polyanionic LbL polyelectrolyte solutions. Briefly, both 
0.05% (w/v) and 0.1% (w/v) chitosan solutions were obtained in a 0,15M NaCl 
aqueous solution. After complete dissolution, the solutions were vacuum-filtered 
with 0.45µm) pore size filter (Schleicher & Schuell Microscience, Germany. The 
pH was adjusted up to 7 using 1M NaOH or 1M citric acid and the solutions 
were stored at 4ºC before microcapsule production.  
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2.2.1.  - Building and characterization of alginate-chitosan multilayers by 
Quartz-Crystal Microbalance with Dissipation Monitoring (QCM - 
D) 
In order to evaluate the LbL assembly of alginate and chitosan 
polyelectrolytes, a Q-Sense E4 system (Q-Sense AB, Sweden) was used. This 
system enables the monitoring of small masses deposition on top of its gold-
coated crystals. The crystals are previously cleaned in an ultrasound bath at 
30ºC, successively immersed in acetone, ethanol and isopropanol to ensure 
that all the impurities are eliminated. Then the crystals are rinsed with distilled 
water and dried with nitrogen gas. Before starting the deposition processes, an 
equilibration step with the rinsed solution is recommended, for approximately 60 
min, to establish the frequency and dissipation baselines. The polyelectrolyte 
solutions were prepared at 0.05% (w/v) and 0.1% (w/v) in 0,15M NaCl. 
Deposition occurred at room temperature (approximately 25ºC) at pH 7.0 in a 
constant flow rate of 100µL/min. Both chitosan and alginate solutions were 
pumped alternatively for 10min each, followed by a 5min wash step with rinsed 
solution of NaCl. The resonant frequency (∆f/n) and energy dissipation (∆D) 
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2.2.2.  Microcapsules production and characterization  
There are two main methods to produce alginate/chitosan capsules in 
mild conditions. The first one is the one-step procedure where the capsules is 
produce by simply letting the alginate droplets fall into a aqueous solution of 
calcium chloride with chitosan. The other is the two-step procedure where the 
calcium-alginate bead is produced by dropping an alginate solution into a 
gelling solution of calcium chloride. The beads were then coated with 
chitosan.[14, 60, 61] 
For this work, it will be used only the two stage procedure, once it has 
been shown that it may result in the binding of 100 times more chitosan than the 
one stag procedure.[60] 
 
2.2.2.1.  Production of calcium-alginate microparticules 
The Calcium-alginate microparticules were produced by ionotropic 
gelation method as described in literature [61, 62]. Briefly, 1% (w/v) alginate 
solution was prepared in 0.15M NaCl. By adding nongelling sodium ions to the 
gelling solution, beads with more homogeneous surface will be produced.[63] 
Then, 1ml of the polymer solution was extrude through a 27G needle (B Braun, 
AG- Germany), using a syringe pump (B Braun, AG – Germany), into 30 ml of 
two calcium chloride (CaCl2 Sigma-Aldrich, Portugal) solution containing 0.5% 
(w/v) or 0.75% (w/v) and 0.15M NaCl. The distance between the needle tip and 
the gelling solution was 10mm. The resulting microparticules were allowed to 
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gel for 20min under stirring. Afterwards the microcapsules were rinsed in 0.15M 
NaCl solution and thoroughly dried using a gaze. All the solutions were 
prepared using distilled water. 
 
 
2.2.2.2.  LbL self assembly deposition 
The calcium-alginate beads were immersed in 20ml of both chitosan 
CL213 0.05% (w/v) and 0.1% (w/v) for 10min. After rinsed in NaCl solution and 
dried, the microcapsules were immersed in 20ml of both alginate solution with 
0.05% (w/v) and 0.1% (w/v) for another 10min. This process was repeated until 
reaching 8 polyelectrolyte multilayers.  
Figure2.3: schematic representation of the procedure used for capsule production using 
ionotropic gelation (1) and layer-by-layer polyelectrolyte assembly (2). 
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The liquid core alginate-chitosan capsules were obtained after 5min 
treatment with 0,05M ethylenediaminetetraacetic acid (EDTA, Sigma -Aldrich, 
Portugal). EDTA is an acid that acts as a metal ions sequestering agent through 
complexation. Due to its hexadentate chemical structure, EDTA binds 
preferentially to divalent cations, such as calcium. Under these conditions, 
EDTA in aqueous solution will chelate calcium cations by removing them from 
the alginate beds, thus leading to a liquefied core. Finally the resulting alginate-
chitosan microcapsules were rinsed in NaCl and stored at 4ºC in the same 
buffer solution for further physical characterization. A few microcapsules were 
also immersed in DMEM in order to access the mechanical stability and the 
permeability to the culturing medium at 37ºC. All this process was performed 
under mild condition. 
 
2.2.2.3.  Morphological characterization 
Morphological characterization is very important to assess the 
structural features of a given system. Aspects like size, shape and general 
topological characteristics are quite simple to obtain using only specific 
microscopy techniques. Stereolight microscope (Zeiss-Stemi 2000-C KL 1500 
LCD, 459315) was used to evaluate the size and topological aspect of the 
produced microcapsules. Scanning Electron Microscopy (Nova Nano SEM 200 
- FEI Company, US), SEM, analysis enables to investigate the presence of the 
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LbL coating and the organization of the polyelectrolyte films deposited around 
the alginate-chitosan microcapsules. 
 
2.2.2.4.  Assessment of alginate-chitosan microcapsules 
mechanical stability by centrifugation  
A short term stability assay was performed to investigate the mechanical 
behavior of alginate-chitosan microcapsules when submitted to hash 
mechanical conditions. The procedure was based on Coradin et al[64] and 
Haque et al[65] with slightly modifications. Briefly, alginate-chitosan 
microcapsules were placed in different centrifuge tubes filled with 0.01M EDTA 
and distilled water. Calcium alginate (Ca-alginate) cores could be decomposed 
by EDTA treatment within the polyelectrolyte multilayer microcapsules[66, 67], 
which therefore allows partial release of alginate molecules from the alginate-
chitosan capsules. Hence, by adding a few amount of EDTA in a solution with 
the liquid core alginate-chitosan capsules, more Ca2+ ions will be chelated 
therefore more alginate molecules will be removed from the capsules. Two 
rotational stress tests were performed on the alginate-chitosan capsules with 
EDTA. The first one was carried out for 60min at 200rpm in a centrifuge at 
25ºC. After this rotating period, the same amount of capsules was centrifuged 
for additional 15min at 4500rpm at the same temperature. The number of intact 
capsules was counted every 15min, during all the rotational stress test. The 
triplicates for each tested condition were made. By conjugating chemical stress, 
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caused by an excess of EDTA, with mechanical rotational stress higher 
destabilization of the multilayered membrane will be achieved which may 
increase the rate of membrane disintegration.  
 
2.2.3.  In vitro studies 
For in vitro studies a human osteoblasts-like cells (SaOs-2 cell line, 
European Collection of Cell Cultures, UK) was used. SaOs-2 like-cells was 
grown as monolayer cultured in 75cm3 culture flasks using Dulbecco’s Modified 
Eagle Medium low glucose (DMEM. Sigma-Aldrich, Portugal) and sodium 
bicarbonate (Sigma-Aldrich, Portugal) supplemented with 10% fetal bovine 
serum (FBS; Biochrom AG, Germany), 1% antibiotic/antimycotic (Invitrogen, 
Portugal) at 37ºC in a 5%CO2 incubator. The culture medium was changed 
every three days and cells were left to grown until confluence. As a cell line, 
SaOs-2 cells were prepared to be immortal and able to maintain their 
phenotypic characteristics for long periods in culture and so can be used in a 
wide range of in vitro tests, namely primarily test with materials. 
 
2.2.3.1.  Cell encapsulation  
Immobilization of cells was performed using SaOs-2 cell line in both 
alginate-chitosan (solid and liquefied) capsules. Capsules and cell 
encapsulation was carried out under mild and sterile conditions in a flow 
chamber. All the solutions were prepared and manipulated as described above.  
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SaOs-2 was culture in culture 75cm3 flasks for few days until reaching 
confluence. SaOs-2 monolayer was initially harvested using trypsin-EDTA 
(Invitrogen, Portugal). Cells were counted using a Neubauer Chamber after 
previous staining with Trypan Blue (vital staining). Approximately 1x106 cells/ml 
were suspended in 1% (w/v) alginate solution. The cell suspension was 
extruded through a 27G needle using a syringe pump into a calcium chloride 
solution. The resulting capsules with cells within were left in CaCl2 solution for 
20 min under stirring at room temperature. A batch of alginate microcapsules 
with cells were placed in 24 well plates with DMEM and incubated in a 5% CO2 
Figure2.4: schematic representation of cell encapsulation procedure in liquid-core capsules. 
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incubator at 37ºC. The following LbL self assembly procedure was performed 
has described above (section 2.2.2.2). The encapsulated cell was incubated in 
a 5% CO2 incubator at 37ºC and culture for 1, 3 and 7 days. The culture 
medium was changed every 3 days.  
 
2.2.3.2. Microscopy observations  
Alginate-chitosan encapsulated cells were observed under light 
microscopy (Stemi 1000 PG-HITEC Zeiss) using the cell filter. For this analysis 
any previous treatment was done. All the capsules (solid and hollow) with cells 
within were permeable to DMEM highlighting the cells inside. With the filter 
applied, the cells appear as small white dots and bright dispersed throughout 
the dish. 
 
2.2.3.3.  Evaluation of Alginate-chitosan encapsulated SaOs-2 like-
cells viability by MTS assay 
Cellular viability and proliferation in alginate-chitosan capsules were 
assessed by MTS using CellTitre 96® (Promega, Madison, USA) a quantitative 
assay. The MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4sulfophenyl)-2H-tetrazolium) test has been describe in the literature.[68] Briefly, 
the metabolically active enzymes in living cells produce dehydrogenases which 
in contact with substrate-MTS convert yellow tetrazolium compound into a water 
solubility brown formazan product. The quantity of brown product is directly 
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proportional to the amount of viable cells. In this study, the MTS solution was 
prepared using DMEM without phenol red and FBS. The MTS CellTitre 96® 
reagent was mixed with the medium in a 5:1 ratio. Approximately 300µl was 
added to alginate-chitosan encapsulated cells and incubated for 3 hours at 
37ºC in a 5% CO2 incubator, protected from the light, in 48 well plates (once the 
MTS reagent reacts in the presence of an extra light source). After incubation 
period, 100µl of each 48 well reaction solution were transferred to 96 well 
plates, in triplicate. The absorbance was read in a microplate reader (BIO-TEK 
– Synergy HT) at 490nm. The results were express in absorbance obtained for 
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A cell encapsulation approach is presented based on the development of 
a nanometeric multilayer coating of polyelectrolytes by the layer-by-layer 
method on alginate spheres. The alginate core material was liquefied using 
calcium chelators in order to produce chitosan-alginate multilayered liquefied 
capsules. All processes were conducted at physiological pH. Human 
osteoblasts-like cells were immobilized into the liquid core capsules for the 
proof-of-concept where their viability was found to increase from 1 to 3 days of 
culture. Such technology has the potential to be used in the biotechnology field 
where the capsules could act as mini-reactors for cells or other microorganisms, 
or in a variety of biomedical applications including cell therapy or tissue 
engineering, in which the multilayered coating can have an immunological 
protection.  
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immunoisolation, self-assemble, QCM 
 
3.1. Introduction  
Bioencapsulation involves the envelopment of tissues or biological active 
compounds in a semipermeable membrane which protects the enclosed 
biological structures from potential hazardous processes in the host 
physiological environment.[1] Various bioencapsulation methods include 
polyelectrolyte complex coacervation, ionotropic gelation and also 
polyelectrolyte coating.[2, 3] 
Since Chang propose the bioencapsulation as an alternative to create 
artificial tissues and organs in 1960’s [4] a wide range of studies in the field of 
cells and bioactive compounds immobilization as been carried out. Many 
semipermeable membranes as well as techniques to improve the capsules 
properties has been presented as alternative methodologies to encapsulate the 
most varied types of cells.[5, 6] Such kind of works have demonstrated that 
bioencapsulation constitute a promising strategy for the treatment of various 
health disorders, ranging from endocrine or central nervous diseases to 
cancer.[7] Actually, the most well succeed developed and clinical implemented 
bioencapsulation devices are those applied in endocrine disorders treatments, 
namely the alginate/poly(L-lysine) microcapsules for pancreatic islet 
immunoisolation.[8-10] 
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The majority of encapsulated encapsulated systems are made by solid 
matrix/core hydrogels, which were reported to cause some biological limitations 
which include long term stability [11], reduced cell growth and protein production 
by exerting stress [7, 12, 13] and low gas an nutrients efficiency capacity.[2] 
Liquid/core matrix has been widely investigated as an alternative to solid 
matrix/core hydrogels, once they appear to allow better cell growth and protein 
production providing higher diffusion of gases and nutrients along the liquid 
matrix.[2, 12, 14, 15] Sun et al showed that cells cultured in liquid core 
microcapsules showed an increase in both intracellular glycerol content and 
stress tolerance substances, while solid core/matrix did not cause any 
significant physiological variation. Moreover, cells released from liquid 
core/matrix were more resistant to hyperosmotic stress, oxidative stress, and 
heat shock stress than cells liberated from solid core/matrix.[16] 
The most common method to obtain capsules with liquid core/matrix is 
through the deposition of one or two layers of oppositely-charge polymers 
around the solid core/matrix, followed by the core liquefaction.[17] The obtained 
membranes could readily be tailored by choosing different combinations of 
polymers for the sequential deposition [18, 19] thus enabling improvement of 
capsule properties such as permeability and stability, preventing the content 
release from the template matrix and ensuring the biocompatibility.[11] Until the 
present date, the vast majority of the studies using liquid core capsules follow 
the model proposed by Lim and Sun in 1980’s [20] in which the semipermeable 
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membrane were obtained by deposition of only two oppositely-charged 
polyelectrolytes, namely alginate and poly(L-lysine) (APA).[5, 21] 
Just a few studies on liquid core capsules have reported the use of more 
than two polyelectrolyte layers. Breguet and co-workers studied the influence of 
4 layered membranes in liquid core APA microcapsule on the long term stability 
and in the proliferation of encapsulated CHO cells. They have concluded that 
such barrier led to an acceleration of CHO cells metabolic activity but did not 
improve the colonization potential of the microcapsules.[12] In a previous study, 
the same group have encapsulated CHO cells in a liquid core capsule which 
was coated using three kinds of interactions generated in the same membrane: 
(1) electrostatic bonds between alginate and poly(L-lysine) (PLL), (2) covalent 
amides bonds between propylene-glycol-alginate (PGA) and PLL, and (3) 
covalent bonds between bovine serum albumin (BSA) and polyglycolic acid 
(PGA). They observed that the mechanical resistance of the capsule only 
decrease by 10% during 1 month in batch mode culture. Cells were 
encapsulated under harsh conditions but their viability was not affected.[22] 
In this work we intent to generalize the concept of immobilizing cells into 
liquefied capsules coated with polyelectrolyte self-assembled multilayers using 
mild conditions in all steps. For the proof-of-concept liquid alginate core 
capsules coated with 8 polyelectrolyte layers of alginate/chitosan were 
processed in cell friendly environment (Scheme 1). The motivation is also based 
on the assumption that natural derived macromolecules exhibit several 
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advantages when used in biomedical applications, including tissue 
engineering.[23] Two methodologies were used for capsule production, namely 
ionotropic gelation and polyelectrolyte layer-by-layer deposition. Alginate beads 
were obtained by ionic crosslink with calcium chloride. A water soluble chitosan 
with high molecular weight was used as the polycationic solution for the 
multilayer coating construction with alginate polyanionic solution. Different 
formulations were tried to obtain liquefied capsules with the best mechanical 
stability. SaOs-2 osteoblast-like cells were used as a model cell source for the 









3.2. Materials and Methods  
3.2.1. Materials 
Water soluble ultrapure chitosan (CHI) salt (PROTOSAN UP CL213, 
viscosity 107mPa.s, molecular weight Mw=2,7x105g/mol, degree of 
Figure3.1: schematic representation of the three-step alginate-chitosan microcapsules 
production. 
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deacetylation DDA=83%) was purchase from Novamatrix (FMc, Norway). Low 
viscosity sodium alginate (ALG) was purchase from Sigma-Aldrich (Portugal). 
 
3.2.2. Quartz crystal microbalance with dissipation monitoring (QCM-D) 
LbL assembly of alginate-chitosan multilayers was measured by Quartz 
Cristal Microbalance with dissipation monitoring (Q-Sense E4 system – Q-
Sense AB, Sweden). The sequential deposition was carried out using two 
different polyelectrolyte concentrations: low polyelectrolyte concentration, 
0.05% w/v (LPC), and high polyelectrolyte concentration, 0.1% w/v (HPC), 
alginate and chitosan solutions. Briefly, a baseline was constructed using a 
0.15M NaCl solution. Then the bidimensional multilayer films were building by 
alternating chitosan and alginate onto the gold crystals. The first coating was 
chitosan (polycation). The polyelectrolyte solutions were injected into the 
measurement chamber for 10min at a flow rate of 100μL/min and a washing 
step of 5min with 0.15M NaCl solution was carried out after each polymer 
adsorption. For all measurements the temperature was set up at 25ºC and the 
pH of all solutions was adjusted to 7. The experience was performed in 
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3.2.3. Preparation of Alginate-Chitosan capsules  
The alginate-chitosan capsules (AC capsules) were produced using a 
three step methodology (Scheme 1). Firstly, alginate beads were produced by 
ionotropic gelation taking place when droplets of 0.5% w/v (formulations A and 
C) or 1% w/v (formulations B and D) sodium alginate solutions were extruded 
through a 27G needle into 0.5% w/v (formulations A and C) or 0.75% w/v 
(formulations B and D) calcium chloride solution and left stirring for 20 min at 
room temperature. The calcium-alginate beads were recovered by filtration in a 
0.22µm filter paper, and rinsed three times in 0.15M NaCl. Secondly, the layer-
by-layer assembly was performed over the surface of alginate beads. The 
sequential deposition was carried out using LPC and HPC alginate and chitosan 
solutions. Ca-alginate beads were incubated for 10min in CHI solutions, rinsed 
two times in NaCl and incubated for another 10min in ALG solutions. The 
procedure was repeated until de 8 alginate/chitosan polyelectrolyte layers 
(ALG/CHI multilayers) were achieved. Finally, the coated Ca-alginate beads 
were treated with 0.05M Etilenediaminetetraacetic acid (EDTA cell culture 
tested – Sigma-Aldrich, Portugal) for 5min to liquefy the AlG core. All the 
solutions used in this procedure, were prepared in 0.15M aqueous solution 
NaCl (Sigma-Aldrich, Portugal) and their pH were adjust to 7. Washing steps 
took place after each polyelectrolyte deposition using 0.15M NaCl as the rinsing 
solution. 
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3.2.4. Capsule characterization 
3.2.4.1. Micro-computerized tomography (μCT)  
The inner structure of the Ca-ALG beads were evaluated by micro-
computerized tomography, µ-CT, using a micro-CT scanner (Skyscan 1702, 
Belgium) with penetrative X-rays of 40 KeV. The X-rays scans were acquired in 
the high-resolution mode. The CT Analyser® software was used to visualize 
and to reconstructs the 2D X-ray images of the capsules. 
 
3.2.4.2. Scanning electron microscopy (SEM)  
AC capsules were deposited onto carbon tape, placed under cupper 
stubs and allowed to air dry. The samples were sputtered with gold and 
observed under Nova Nano SEM 200 (FEI Company, US). 
 
3.2.4.3. Alginate-Chitosan capsules stability test  
The ability of AC capsules to sustain the mechanical stress of rotation 
was determined using a centrifuge.[21, 24] Approximately 50±10 AC capsules 
were placed in centrifuge tubes containing 0.01M EDTA (in 0.15M NaCl 
solution). The tubes were rotated for 60min at a speed of 200rpm at 25oC and 
followed by additional 15min of rotation at a speed of 4500rpm at the same 
temperature. The number of damaged capsules were observed and counted 
under a light microscope every 15min of centrifugation.  
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3.2.5. Cell culture and encapsulation 
A human osteoblast-like cell line (SaOs-2 cell line, European Collection 
of Cell Cultures, UK) were cultured in Dulbecco’s Modified Eagle Medium 
(DMEM, Sigma-Aldrich, Portugal) supplemented with 10% fetal bovine serum 
(FBS, Biochrom AG, Germany) and 1% antibiotic/antimycotic solution (Gibco, 
UK). Cells were incubated at 37ºC in a 5% CO2 atmosphere incubator. 
Confluent cells were harvested and suspended in 1% w/v alginate 
solution, to a final ratio of 1.0x106 cells per ml of alginate. The encapsulation 
procedure as well as the LbL polyelectrolyte assembly was performed as 
previously describe for the AC capsules preparation using HPC polyelectrolyte 
solutions to construct the ALG/CHI multilayer membranes. All the process was 
carried out in a sterile flow chamber at room temperature under mild conditions. 
 
3.2.5.1. Cell viability assay 
The cell viability was determined using the MTS assay. This assay is based 
on the bioreduction of a tetrazolium compound, 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulphofenyl)-2H-tetrazolium (MTS – CellTitre 96®, 
Promega, Madison, USA) into a water-soluble brown formazan product. The 
optical density (OD) was quantified by UV-spectroscopy, reading the formazan 
absorbance at 490nm in a microplate reader (Bio-Tek, Synergie HT, USA). 
Results were compared to the cell viability on the culture plate, as assay 
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control, and to the AC capsules without cells, stated as sample control. The 
samples were analyzed in triplicate per each time point.  
 
3.3. Results and discussion  
3.3.1. Quartz crystal microbalance with dissipation monitoring (QCM-D)  
QCM-D experiments were performed initially to monitor the formation of 
ALG/CHI multilayers on planar surfaces using LPC and HPC polyelectrolyte 
solutions. Figure 1 shows the build-up of 8 polyelectrolyte layers using LPC and 
HPC solutions at pH 7. The decrease of film ∆f/n – see Fig. 1A - after each 
polyelectrolyte adsorption step suggests that mass is being deposited at the 
crystal surface in both studied conditions. Moreover the sequential deposition 
occurs as a stable process giving rise to film with a continuous increase in the 
thickness and with a systematic increase of the viscoelastic behavior due to the 
steady increasing in ∆D – see Fig. 1B. The obtained results were very similar to 
those achieved in a previous study, where the same chitosan, but with a low 
molecular weight, was used to construct multilayers with low viscosity alginate 
at pH 7 and at room temperature.[25] Assuming a simple viscoelastic model and 
some characteristic values of densities and viscosity of the liquid medium we 
estimate that in both HPC and LPC multilayered membranes the thickness was 
around 100nm after the deposition of 8 the layers.  
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The QCM-D experiments demonstrate that stable ALG/CHI multilayers 
can be produced by layer-by-layer using high molecular weight chitosan 
(CL213) and alginate under physiological simulated conditions. Such system 
was used to coat Ca-alginate beads. 
 
 
3.3.2. Alginate-Chitosan capsules morphologic characterization 
Stereoligth microscopy observations revealed that the Ca-alginate beads 
exhibit a spherical-like shape with a diameter in the range 2.0-2.5 mm – see 
Fig.2A. 
µ-CT analyze was performed on air dried Ca-alginate beads and 
revealed a lamellar-like organization of the material – see Fig.2B. The structure 
Figure3.2: QCM-D results showing the deposition of 8 ALG/CHI layers films at pH 7 with low 
polyelectrolyte concentration (LPC –circles) and high polyelectrolyte concentration (HPC – 
squares). (A) Normalized frequency (∆f/n) and (B) dissipation (∆D) variations are recorded as a 
function of time. Steps 1 and 3 represent chitosan and alginate deposition, respectively, and 
step 2 is related to rinsing with saline buffer NaCl. Plots represent the 7th, 9th, and 11th 
harmonics for HPC frequency (solid squares) and dissipation (open squares) and the 7th, 9th and 
11th harmonics for LPC frequency (solid circles) and dissipation (open circles) at pH 7.0.   
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can possibly be a result of the water leaching during the air drying which leaves 
the corresponding fingerprint in the solid hydrogel. Such kind of lamellar 
morphology was also observed in the interior of the Ca-alginate dried beads by 
SEM – see Fig.2C, being consistent with the μ-CT results. 
After the multilayer coating and the liquefaction process the AC capsules 
were obtained. The pH of the polyelectrolyte solutions used in this study was 7. 
Although chitosan is known to be soluble in low pH conditions, it was shown 
before that it is possible to increase the pH of these types of soluble chitosan 
until 7 without polymer precipitation, and that such solutions can be used 
together with the alginate solution in the build-up of ALG/CHI multilayers.[25] 
Figure 2D shows a representative liquid core AC capsule exhibiting a well 
preserved and homogenous multilayered membrane build at mild conditions 
and pH 7. The dimension of the AC capsules is similar to the Ca-alginate 
beads. 
Polyelectrolyte deposition over the Ca-alginate bead was investigated by 
means of SEM analysis. Figure 2E shows the organization of the polymeric 
membranes evolving the liquid core of AC capsules. It is clear the layered-like 
organization of the membrane that also displays a quite smooth surface. The 
membrane thickness of polyelectrolyte multilayers build on the Ca-alginate 
beads with HPC is of the order of the micron-scale which contrasts with the 
much thinner thickness observed in the ALG/CHI multilayres developed in 
planar gold substrates as monitored by QCM-D. This could be explained by the 
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partial diffusion of chitosan within the Ca-alginate beads producing a dense 
layer stabilized by complexation. 
 
3.3.3. Alginate-Chitosan capsules stability test  
Table 1 shows the four different Ca-alginate beads formulations used as 
templates for LBL assembly. LPC and HPC solutions were used to coat the 
surface of Ca-alginate beads previously prepared by precipitation of 0.5% w/v 





Table3.1: Concentration of the sodium alginate and calcium chloride solutions used to prepare 
the different liquid core capsules. 
 
The mechanical stability of the AC capsules subjected to EDTA treatment 
is resumed in figure 3. All capsules were coated with 8 layers using LPC (solid 
Figure3.3: (A) – Calcium-alginate bead observed by optical microscopy; (B) – alginate 
organization observed by μ-CT analysis; (C) – SEM of the interior of Ca-ALG beads; (D) –  
alginate-chitosan liquid core capsule observed by optical microscopy; (E) –  SEM of the 
alginate-chitosan coating organization of the AC capsules; 
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symbols) or HPC solutions (open symbols). It is noticeable that the capsules 
prepared using HPC solutions presented a much better stability with respect to 
the LPC solutions. This could be due to a more extent of complexation of the 
first chitosan multilayer with the Ca-alginate bead that can form a more robust 
layer - see Fig. 2E. Moreover the capsule prepared with higher concentrations 
of alginate (B and D) are more stable but this effect is mainly seen when the 

















Figure3.4: The effect of the mechanical impact of rotation at 200rpm and 4500rpm on the 
integrity of the four types of liquid core capsules as function of time. 
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3.3.4. Cell viability assay 
Taking into account the results obtained from the mechanical stability 
tests, cell encapsulation was only performed in AC capsules whose membranes 
were build using HPC solutions.  
SaOs-2 cells were encapsulated in 8 layers AC capsules to evaluate the 
in vitro biocompatibility of the developed system. Optical microscopy images 
after 1 day of culture shows that cells were entrapped and uniformly distributed 
inside the AC capsule – see Fig. 4A1. After 3 days of culture the cells tend to 
attached to the inner side of the multilayred membrane that is consistent with 
the adherent nature of the cells – see Fig. 4A2. Previous studies also concluded 
that cells encapsulated in large liquid microcapsules (>1mm) generally tent to 
move through the capsules periphery were the gas and nutrient diffusions are 
more efficient.[15, 26] 
The viability of the encapsulated SaOs-2 cells was assessed using MTS 
assay - see Fig.4B. The results suggested that the cell viability increases 1 day 
to 3 days of culture. This indicates that cell viability is not affected by the 
multilayered build up process, even though the time required for their production 
has been approximately 3h. This can be explained by the fact that mild 
conditions has been ensured since the beginning with the selection of water 
soluble and biocompatible natural-based polymers which were manipulated at 
physiological pH and at room temperature. Moreover, the salt and 
polyelectrolyte concentrations were appropriate to maintain the capsules and 
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the encapsulated cells in a adequate ionic strength and osmotic pressure 
















3.4. Conclusions  
In this work the possibility of encapsulating cells within a multilayered 
liquid core capsule without compromising the cell viability was demonstrated. A 
water soluble chitosan with high molecular weight was used as a polycation to 
produce multilayered membranes by alternate deposition with oppositely-
charged alginate. The polyelectrolyte LbL was performed onto ionotropic gelled 
Ca-alginate capsules with previously entrapped cells. The main goal of this 
study was to encapsulate cells in liquid core capsules at the mildest condition 
Figure3.5: (A) –Cells encapsulated in 8LbL AC capsules after 1day (A1) and 3 days (A2) of 
culture seen by optical microscopy; (B) – MTS viability assay of encapsulated cells after 1 day 
and 3 days of culture. (*) – Significance level of 95% (p < 0.05). 
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as possible, so, neutral pH was employed for all the polymers which were 
prepared in physiological saline buffer under room temperature and in sterile 
conditions. Low and high concentrations of polyelectrolyte solutions were used 
to prepare capsules multilayered membranes and their mechanical stability was 
assessed. Results revealed that multilayered membranes prepared with high 
polyelectrolyte concentration were mechanically more stable and not so 
dependent from the Ca-alginate initial concentrations. SaOs-2 cells were 
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Chapter IV: Preliminary study on the encapsulation of PLLA 
microparticles seeded with cells onto liquefied capsules 
 
4.1. Introduction 
Cell encapsulation in liquid-core matrix with a spherical shape has been 
a widely applied methodology to entrap living cells and bioactive compounds. 
Among the numerous biomaterials candidates, hydrogels have shown great 
promise due to their unique advantages.[1-3] Generally, hydrogels provide highly 
hydrophilic and bio-inert microenvironment in which the suspended cells are 
constrained to a round shape environment.[4, 5] This feature may be a drawback 
since the majority of encapsulated living cells are anchorage-dependent cells 
(ADCs), which require a surface to attach and spread in order to maintain their 
natural phenotype.[6, 7] 
Non-collagen and un-modified hydrogels are known to be lack of cellular 
integrin receptors.[8, 9] In normal condition this receptors binds to specific ligands 
triggering intracellular signaling cascades which prevents cell apoptosis and 
activates cytoskeletal reorganization.[6, 10] In the absence of these receptors the 
entrapped ADCs are unable to naturally anchor to polymer matrix.[11] Moreover, 
physical enclosing by the round-shape liquid-core matrix may submit the ADCs 
to an undesirable environment which may be ineffectual for the cells spreading 
in the hydrogels.[12] 
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In order to improve the cell adhesion and proliferation in hydrogel matrix, 
inert polymeric chains can be tailored with select biological moieties to yield 
bioactive materials. The most common procedure to attain this level of 
bioactivity is the inclusion of Arginine–Glycine–Aspartic acid (RGD) tri-peptide.[2, 
13, 14] This specific amino acid sequence is a prototypical oligopeptide ligand 
which can be found in the adhesive proteins such as fibronectin and vitronectin. 
Usually this ligand binds to α4β1 integrin receptors expressed on the cell 
surface enhancing cell adhesion, spreading, proliferation and phenotype 
expression in in vitro cultures.[15-18] Recently, fibronectin or RGD itself has been 
used to modify polyelectrolyte film surfaces for cell adhesion[19], in cell sheets 
constructions[20-22], or in the production of polymeric matrix microcariers for 
ADCs delivery.[23-25] 
In this study cells were immobilized in spherical annular Ca-alginate gels 
that provide and aqueous and three-dimensional environment for the cells. To 
provide immune isolation and mechanical stability Ca-alginate core was coated 
with alginate-chitosan multilayers using an identical procedure to what we have 
previously related – see Chapter 3. In the earlier encapsulation anchorage-
dependent cells were entrapped inside liquid-core capsules and coated with 
alginate-chitosan polyelectrolytes using LbL methodology. Incubation with 
EDTA leads to the diffusion out of high amount of calcium ions bonded to the 
polyguluronate sequences. This event is responsible for the loose of the “egg 
box” structure (solid core) and core liquefaction.[26, 27] In the presence of liquid-
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core matrix and regarding the large diameter of the capsules (>1mm) ADCs 
usually tend to form cell clusters within the core matrix and become deprived of 
oxygen and nutrients.[28] On the other hand, a few amounts of cells seem to 
migrate to capsule membrane, and attached on it, since it is the only solid 
structure available to attach on. As a result, cells are not dispersed throughout 
the core and became necrotic.  
Here, an alternative method for encapsulating living anchorage-
dependent cells in liquid-core capsules containing solid particles within is 
presented. The possibilities to have additional solid surface where the cells can 
attach and proliferate represent a recent concept for increasing the loading 
capacity of aqueous capsules.  
 
4.2. Materials and Methods 
4.2.1. PLLA particles processing 
For this work polylactic acid (PLLA – Mn=69000, from Cargill Dow, USA) 
microparticles were obtained by milling (Ultra Centrifugal ZM 200, Retsch - 
Germany. Briefly, some PLLA beads, used as received, were milled four times 
and their range was estimated using a particle weight separator (Sieve Shaker 
As 200, Retsch - Germany). The processed microparticles had rough surface 
morphology and ranged between 125µm - 250µm. For further use in in vitro 
studies, the PLLA microparticles were sterilized in Pronefro (Portugal). The 
morphology of the PLLA microparticules was confirmed by means of Stereoligth 
Microscopy and Scanning Electron Microscopy (SEM).  
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In our group PLLA has been used in various formulations for studies of 
cell adhesion and proliferation, often showing good results. Material properties 
or the scaffolding that it will integrate can be controlled through the surface 
modification[29] or previous treatments applied to the material.[30-32] 
 
4.2.2. Cell culture studies 
Both cell line of osteoblastic like cells (SaOs-2) and fibroblastic like cells 
(L929) were selected for the in vitro studies once they are the most applied cells 
in preliminary studies with biomaterals. The cell lines were obtained from 
European Collection of Cell Cultures (ECC, UK) and were cultured in 75 cm3 
culture flasks using Dulbecco’s Modified Eagle Medium (DMEM, Sigma-Aldrich, 
Portugal) supplemented with 10% fetal bovine serum (FBS, Biochrom AG, 
Germany), 1% antibiotic/antimycotic (Invitrogen, Portugal) and sodium 
bicarbonate (Sigma-Aldrich, Portugal) at 37oC in a 5% CO2 incubator. The 
culture medium was changed every two days and cells were growth until 
confluence, before any in vitro assay. A fraction of the PLLA microparticles was 
treated with human fibronectin (Biopur, Swiss) and both treated and untreated 
PLLA microparticles were seeded with cells and cultured for different periods of 
time. The cells adhesion and proliferation onto PLLA microparticles were 
assessed by microscopy and MTS assays. PLLA microparticles with cells 
seeded onto were encapsulated in alginate-chitosan liquid-core capsules and 
culture for different periods of time.  
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4.2.3. Seeding and culturing osteoblast like-cells and fibrobroblast like-
cells into PLLA microparticules with and without fibronectin 
treatment 
The aim of this study was to investigate differences in cells adhesion and 
proliferation onto both PLLA microcaparticles treated with human serum 
fibronectin and untreated. 
The procedure was made according to Custósio et al[33] with slightly 
modifications. Briefly, PLLA microparticles were placed in 24 well plates in order 
to have 1mg of sample per each well. 12 wells containing the PLLA 
microparticles were treated with 1ml of a solution containing 0,15M NaCl and 
100µl of human serum fibronectin. The other 12 wells were maintained with 
0,15M NaCl. The 24 culture well plate with PLLA samples was incubated for 
24h at 37oC in a 5% CO2 incubator. After the incubation time, the solutions were 
removed, and 3,0x105 SaOs-2 and L929 cells were seeded – see Figure 4.1. 
The plate was incubated for 2h at 37oC in a 5% CO2. At the end of the 2h for 
cell and material contact, 1ml of culture medium DMEM were added to each 
well and the samples were incubated in the same conditions previously 
described for different periods of time. Microscopy and MTS assay were 
performed in order to evaluate the cells adhesion, proliferation and viability 
along 3 days. 
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4.2.4. Staining procedure for microscopy analysis 
From the 24 well sample culture plaque, one well of each studied 
condition were used for microscopy analysis. Briefly, each of the four wells were 
washed two times in PBS and incubated with formalin for 30 min at 37oC in a 
5% CO2 incubator. Formalin was used to fix cells and maintain the culture safe 
from microbial. After the fixation time, the formalin was removed and the wells 
were again washed once with PBS. A solution containing 1ml of PBS and 10µl 
of methylen blue was added to each well and the plaque was incubated for 10 
min at the same conditions. Methylen blue was used as a cell dye. The stained 
samples were analyzed under the conventional microscope.  
 
4.2.5. MTS quantification of viable cells 
The cell viability and proliferation under the PLLA microparticules were 
assessed using the CellTitre 96® MTS reagent (Promega, Madison, USA). For 
the viability quantification, cell culture medium DMEM was prepared without 
phenol red and FBS and was mixed with MTS reagent in a (5:1) ratio. 
Afterwards, 300µl of MTS solution was added to each sample culture well and 
incubated in the dark for 3h at 37oC in a 5% CO2 incubator. After the incubation 
time, 100µl was transferred from each culture well to a 96 well plaque (with the 
respectively triplicates) and the absorbance was read in the microplate reader 
(BIO-TEK-Synergy HT) at 490 nm. A blank solution, with MTS solution and 
samples without cells, was made as assay control. The MTS graph was 
constructed with the corrected values, i.e., all the values read for samples with 
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cells menus the assay control. The time points selected for this study were 24h, 
48h and 72h. 
 
4.2.6. Encapsulation of PLLA microparticules with cells in alginate-
chitosan capsules 
Cell seeding onto PLLA microparticles was carried out as describe earlier 
in 2.2.1 in both 1mg and 0.05mg of sterilized PLLA microparticles. A low 
viscosity sodium alginate (Sigma-Aldrich, Portugal) was used to prepare 1.5% 
alginate solution in 0.15M NaCl. The polymeric solution was vacuum-filtered in 
a 22µm pore-size filter (Schleicher & Schuell Microscience, Germany) to 
sterilize. 10ml of the sodium alginate solution were added to PLLA 
microparticules with cells in order to obtain two different cell/microparticles 
suspensions with a final ratio of 0.05mg/10ml and 1mg/10ml. Capsules were 
Figure4.1: schematic representation of the procedure used for seeding and culturing SaOs-2 
and L929 cell lines onto PLLA microparticles treated and untretaed with human fibronectin. 
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produced using a Pasteur pipette instead of a needle, once its diameter allows 
the flux of both suspensions containing PLLA microparticles. The suspensions 
were extruded separately to a 1% calcium chloride (Sigma-Aldrich – Portugal) 
solution prepared in 0.15M NaCl, and left gelling for 20min under stirring at 
room temperature. The following encapsulation procedure such as the layer-by-
layer multilayer construction and the liquid-core capsule production was 
performed according to what was already described in Chapter 3. The 
encapsulated cell/microparticles were incubated in a 5% CO2 incubator at 37ºC 





Figure4.2: Schematic representation of the procedure used to prepare liquid-core 
alginate/chitosan capsules containing cells seeded onto PLLA microparticles. 
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4.3. Results and Discussion 
4.3.1. Cellular adhesion and proliferation 
PLLA microparticles were seeded with SaOs-2 and L929 cell lines in order 
to evaluate the cell/material interaction with respect to cell adhesion and 
proliferation. Optical microscopy revealed that both cell lines have attached to 
the surface of both fibronectin treated and untreated PLLA microparticles after 
the 72h of culture. However, fibroblastic cell line, L929, shows to adhere better 
than the osteoblastic cell line, SaOs -2 in both tested conditions. Moreover, it 
seems that PLLA microparticles surface previously treated with human 











Figure4.3: Optical microscopy cells cultured onto untreated PLLA microparticules (A – SaOs-2 
and D – L929) and fibronectin treated PLLA microparticles (B – SaOs-2 and E – L929) after 72h. 
C and F represents, respectively, SaOs-2 cells and L929 cells cultured for 72h at 37ºC (positive 
control). A, B, C and F were obtained using a magnification of 40X. D and E were obtained 
using a magnification of 20X. 
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Regarding to the cell morphology, it was possible to observe that unlike 
the controls (cells in culture) the cells seeded onto both PLLA formulations were 
round and not express pseudopodias. This cell behavior on the PLLA 
microparticules can be explained by the solid particle formulation which is the 
result of the processing method applied. Actually, several studies have 
confirmed that cells adhesion and proliferation strongly depends on the material 
surface characteristics.[34-38] Other studies have shown that the thickness and 
rigidity of a substrate can affect cell attachment and alter cell shape.[39-43] 
Moreover, Salloum et al demonstrate that cell morphology and motility depends 
more on the hydrophobicity and charge on top of the material than on the 
thickness of the material.[44] So, to achieve a suitable solid surface which elicits 
cell adhesion and proliferation, further improvements in the solid particles 
processing must be taken into account.  
 
4.3.2. MTS quantification of viable cells 
Figure 4.4 shows the results obtained by the MTS assay after 72h of 
culturing cells onto PLLA microparticles treated and untreated with human 
fibronectin serum. The results show an increasing cell density for both cell lines 
during the culturing time. However, it is clear the high adhesion and proliferation 
capacities of the fibroblastic like-cell when compared with osteoblastic like-cells. 
Fibroblast adhesion and proliferation seems to happen faster and easily 
during the first 48h when the PLLA microparticles are treated with human 
fibronectin serum. On the other hand, after 72h of culture there were no 
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significant differences between the optical densities (O.D) of cells cultured onto 
treated and untreated PLLA microparticules. This situation may be explained by 
(1) the high ability to induce cellular adhesion express by the extracellular 
matrix proteins, such as fibronectin, which may have a critical role during the 
first 48h of culture and (2) the anchorage-dependent behavior of the living cells 
which naturally impels them to attached on a solid surface, which may justified 
the increasing of adherent and proliferating cells on untreated PLLA 
microparticles after 72h. These results are in agreement with the optical 









Nevertheless, the O.D of cells seeded in the PLLA microparticles after the 
72h are slightly low in comparison with the amount of cells in culture (positive 
Figure4.4: Cell viability and proliferation of SaOs-2 cells and L929 cells cultured onto 
untreated and treated PLLA microparticles. The results were obtained using MTS assay after 
24h, 48h and 72h. 
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control) for the same period of culturing, which may be explained by the loose of 
PLLA micropartcles during the procedure to preparing samples for MTS assay.  
 
4.3.3. Encapsulation of PLLA microparticules with cells in alginate-
chitosan capsules 
Figure 4.5 shows the encapsulated PLLA microparticles with cells seeded 
onto. From the pictures it is only possible to observe the PLLA microparticles 
within the liquid-core capsules. Due to the considerable diameter of the 
alginate/chitosan capsules (>3mm) none of the attempted microscopy 
techniques allowed us to visualize the cells seeded onto the solid PLLA 
microparticles. Thus, even though the cells are actually present in the 
encapsulated material, the images obtained cannot confirm it.  
 
 
Figure4.5: Alginate-chitosan liquid core capsules containing PLLA microparticules with cells 
seeded onto. A – Capsule with 0.05mg of PLLA microparticles, magnification of 40X; B – 
capsule with 1mg of PLLA microparticles, magnification of 20x; C – PLLA microparticles 
dispersed within liquid-core matrix, magnification of 40x. 
Preparation and characterization of polysaccharide 
multilayered capsules for tissue engineering applications 
Chapter IV: Preliminary study on the encapsulation of PLLA 





In the field of biomaterials, controlling the surface mechanical properties 
may be a means of influencing cell behavior including re-colonization, adhesion, 
and migration.[45] Proteins play an important role in the adhesion, spreading, 
and growth of cells.[44] For its part, the cell physiology itself (morphology and 
functionality) affects the mechanism of the adhesion (specific and unspecific)[46] 
and consequently its proliferation. In this preliminary study we observe that 
incorporation of solid particles in liquid-core capsules could be a good 
alternative to provide a solid surface for adherent cells dispersed in a 
liquefied/viscous environment. Here we suggest PLLA microparticles as the 
solid surface for cell adhesion, but, in principle, a wide range of bioactive or 
even inorganic materials can be used as cell support. Once the techniques 
used for the production of these systems are quite facile and versatile, all the 
components presented here can be manipulated differently depending on its 
further application. Therefore, the capabilities of this system are very promising 
once it allows the applications of a wide range of natural or synthetic 
biomaterials not only in the buildup of the liquid-core matrix and polyelectrolyte 
multilayers but also in the development of the solid inclusion particles. Still, the 
processing techniques of materials may also be the most varied bearing in mind 
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In the field of bioencapsulation a continuous effort has been done in 
order to prepare liquid-core capsules based on different formulations. However 
up to now, a lot of works still has to be done in order to establish these liquefied 
capsules as a potential and viable alternative for cell encapsulation. Some 
Improvements can be carried out in order to obtain clinically successful devices. 
They may be for example, (1) stabilization of the chemical and physical 
boundings between the materials used, whether to form the core or to build the 
capsule wall, in order to improve the mechanical properties of the capsules; (2) 
the development of brand new combinations of natural and synthetic polymers 
with higher toughness and malleability; (3) the inclusion of peptides or bioactive 
compounds to enhance the biocompatibility; (4) surface modifications of the 
capsule walls by the construction of different numbers of layers with the most 
varied types of macromolecules; (5) choice of new materials that can be used 
as liquid-core templates in cell friendly procedures.  
With the continuous advances in genetics, biotechnology, chemical and 
biological sciences the improvements will lead to progressions in tissue 
engendering and regenerative medicine. Moreover, bioencapsulation may 
become one day closer to a realistic proposal to clinical application.  
 
 
